- Home
- TNGX vs CCCS Comparison
TNGX vs CCCS Comparison
Compare TNGX & CCCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- CCCS
- Stock Information
- Founded
- TNGX 2014
- CCCS 1980
- Country
- TNGX United States
- CCCS United States
- Employees
- TNGX N/A
- CCCS N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- CCCS Computer Software: Prepackaged Software
- Sector
- TNGX Health Care
- CCCS Technology
- Exchange
- TNGX Nasdaq
- CCCS Nasdaq
- Market Cap
- TNGX 351.2M
- CCCS 5.8B
- IPO Year
- TNGX N/A
- CCCS N/A
- Fundamental
- Price
- TNGX $5.43
- CCCS $9.70
- Analyst Decision
- TNGX Strong Buy
- CCCS Buy
- Analyst Count
- TNGX 6
- CCCS 7
- Target Price
- TNGX $12.20
- CCCS $12.14
- AVG Volume (30 Days)
- TNGX 3.3M
- CCCS 9.1M
- Earning Date
- TNGX 08-06-2025
- CCCS 07-29-2025
- Dividend Yield
- TNGX N/A
- CCCS N/A
- EPS Growth
- TNGX N/A
- CCCS N/A
- EPS
- TNGX N/A
- CCCS 0.01
- Revenue
- TNGX $40,990,000.00
- CCCS $969,128,000.00
- Revenue This Year
- TNGX N/A
- CCCS $13.36
- Revenue Next Year
- TNGX N/A
- CCCS $9.24
- P/E Ratio
- TNGX N/A
- CCCS $760.61
- Revenue Growth
- TNGX 10.09
- CCCS 9.05
- 52 Week Low
- TNGX $1.03
- CCCS $8.14
- 52 Week High
- TNGX $12.02
- CCCS $12.88
- Technical
- Relative Strength Index (RSI)
- TNGX 69.60
- CCCS 65.16
- Support Level
- TNGX $4.80
- CCCS $9.17
- Resistance Level
- TNGX $5.63
- CCCS $9.64
- Average True Range (ATR)
- TNGX 0.52
- CCCS 0.27
- MACD
- TNGX -0.05
- CCCS 0.05
- Stochastic Oscillator
- TNGX 66.03
- CCCS 86.79
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About CCCS CCC Intelligent Solutions Holdings Inc.
CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, and AI-enabled digital workflows. It operates in a single segment being Domestic segment which provides SAAS platform for the P&C insurance economy and derives revenues from providing customers with software subscriptions to the platform in addition to providing professional services and non-software services. The company has its presence in United States and China. Majority of the revenue is generated from United States.